DOLTENDIX

Serial Number 79297326
Registration 6571369
700

Registration Progress

Application Filed
Sep 29, 2020
Under Examination
Approved for Publication
Sep 14, 2021
Published for Opposition
Sep 14, 2021
Registered
Nov 30, 2021

Trademark Image

DOLTENDIX

Basic Information

Serial Number
79297326
Registration Number
6571369
Filing Date
September 29, 2020
Registration Date
November 30, 2021
Published for Opposition
September 14, 2021
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 30, 2021
Registration
Registered
Classes
005

Rights Holder

KOLINPHARMA S.P.A.

35
Address
Via Larga, 8
I-20122 MILANO
IT

Ownership History

KOLINPHARMA S.P.A.

Original Applicant
35
IT

KOLINPHARMA S.P.A.

Owner at Publication
35
IT

KOLINPHARMA S.P.A.

Original Registrant
35
IT

Legal Representation

Attorney
Caleb Norris

Application History

27 events
Date Code Type Description
Mar 29, 2024 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Jun 12, 2022 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
May 21, 2022 FICS P FINAL DISPOSITION NOTICE SENT TO IB
May 20, 2022 FIMP P FINAL DISPOSITION PROCESSED
Apr 29, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Feb 28, 2022 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 30, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Sep 14, 2021 PUBO A PUBLISHED FOR OPPOSITION
Sep 14, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 26, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 6, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 4, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 3, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 3, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 22, 2021 RFNT P REFUSAL PROCESSED BY IB
Feb 27, 2021 RFRR P REFUSAL PROCESSED BY MPU
Feb 27, 2021 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 25, 2021 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 24, 2021 CNRT R NON-FINAL ACTION WRITTEN
Feb 23, 2021 DOCK D ASSIGNED TO EXAMINER
Nov 10, 2020 MAFR O APPLICATION FILING RECEIPT MAILED
Nov 6, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 5, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 005
Pharmaceuticals and pharmaceutical preparations for treating osteoarticular diseases; dietary, nutritional, mineral, dietary nutraceutical, and vitamin supplements and preparations for medical purposes; dietary enzyme and protein supplements; dietetic food and preparations adapted for medical purposes; all the aforesaid goods for use in the osteoarticular field
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of a shaded hexagon carrying the image of a human foot. To the right of the hexagon, the stylized wording "DOLTENDIX" appears.

Classification

International Classes
005